How does adding PD-(L)1 inhibitors to platinum-etoposide treatment of small cell lung cancer improve survival outcomes?
0 citations
Abstract
1. The introduction of immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis has improved survival outcomes in patients with both extensive stage (ES, 60-70% of cases) and limited stage...
// Source
Authors: Maria Giovanna Formelli, Adriana Di Odoardo, Elisa Andrini, Giuseppe Lamberti
Institutions: University of Bologna